Between Jan. 1, 2008, and Dec. 31, 2015, Dr. Mitias and his clinic allegedly submitted false claims for brand-name knee injection agents that weren’t administered to Medicare and Medicaid beneficiaries, the report said. Instead, a cheaper compounded agent was allegedly used while Dr. Mitias claimed higher compensation for the brand-name products.
The settlement resolves allegations brought forth by a medical device sales representative under the whistleblower provisions of the False Claims Act.
Mitias Orthopaedics has a subsidiary also named in the allegations, Olive Branch, Miss.-based Champion Orthopedics.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
